Potential for developing a SARS-CoV receptor-binding domain (RBD) recombinant protein as a heterologous human vaccine against coronavirus infectious disease (COVID)-19-Reference-Cited by-同舟云学术

Potential for developing a SARS-CoV receptor-binding domain (RBD) recombinant protein as a heterologous human vaccine against coronavirus infectious disease (COVID)-19

Published:2020-04-16 Issue:6 Volume:16 Page:1239-1242
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Chen Wen-Hsiang¹²,Hotez Peter J.¹²³^ORCID,Bottazzi Maria Elena¹²³

Affiliation:

1. Texas Children’s Hospital Center for Vaccine Development, Departments of Pediatrics, Baylor College of Medicine, Houston, TX, USA

2. National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA

3. Molecular Virology & Microbiology, Baylor College of Medicine, Houston, TX, USA

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2020.1740560

Reference22 articles.

1. World Health Organization. WHO director-general’s remarks at the media briefing on 2019-nCoV on 11 February 2020. Ed; 2020 [cited 2020 Apr 2]. Available from: https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020

2. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia

3. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany

4. Optimization of the Production Process and Characterization of the Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1), a SARS Vaccine Candidate

5. Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome

Cited by 131 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SARS-CoV-2 evolution has increased resistance to monoclonal antibodies and first-generation COVID-19 vaccines: Is there a future therapeutic role for soluble ACE2 receptors for COVID-19?;Antiviral Research;2024-07

2. MultiTEP-Based Vaccines Targeting SARS-CoV-2 Spike Protein IgG Epitopes Elicit Robust Binding Antibody Titers with Limited Virus-Neutralizing Activity;Pathogens;2024-06-20

3. Production of functional antibodies from hyperimmune duck eggs for neutralization of new coronavirus SARS CoV-2;Biopolymers and Cell;2024-06-18

4. Computational design and investigation of the monomeric spike SARS-CoV-2-ferritin nanocage vaccine stability and interactions;Frontiers in Molecular Biosciences;2024-06-12

5. The zebrafish as a potential model for vaccine and adjuvant development;Expert Review of Vaccines;2024-05-09